[Gender-specific aspects of Lynch syndrome--an update].
Approximately 3-5% of all colorectal cancers are based on a hereditary predisposition, of which Lynch syndrome is by far the most frequent hereditary cancer syndrome. Beside colorectal cancer Lynch-Syndrome is the most frequent predisposing hereditary cause of endometrial cancer and is also associated with gastric cancer, ovarian cancer, cancer of the urinary tract as well as several other cancers. Genetically Lynch syndrome is caused by a germline mutation in one of the so-called mismatch-repair-genes. Based on several epidemiological studies, increasingly differences in the penetrance of the different cancers occurring are associated with the affected gene and also gender of the patient have been reported. The lifetime risk of colorectal cancer for males with Lynch syndrome generally is significantly higher and the age of first manifestation significantly earlier compared to females. The difference is especially notable in men with a MSH6-mutation. Moreover, the lifetime risk for gastric, bladder, and urothelial cancer is much higher in males. Women with an MSH6 mutation have a much higher risk for endometrial (and ovarian) cancer than for colorectal cancer. In patients with Muir Torre syndrome again males are predominantly affected and almost all affected have a mutation in MSH2 rather than in any other MMR gene. This review is an update of the literature analyzing gen and gender specific aspects of Lynch syndrome. To date these associations are based on retrospective studies, that require confirmation in a prospective setting with large patient numbers in order to identify validated, individualized gene and gender screening recommendations in the future. Especially in a syndrome with multiple potential cancer targets, an intense yearly program comprising several invasive procedures has a negative effect on patient compliance.
Department of Hereditary Tumor Syndroms; Surgical Center, HELIOS Clinic, University Witten/Herdecke; Wuppertal, Germany.
R
R
Schneider
Department of Surgery, Caritas-Hospital St. Josef, Regensburg, Germany.
A
A
Fürst
Department of Hereditary Tumor Syndroms; Surgical Center, HELIOS Clinic, University Witten/Herdecke; Wuppertal, Germany.
G
G
Möslein
D017677:Age Distribution; D003123:Colorectal Neoplasms, Hereditary Nonpolyposis / Q000175:diagnosis / Q000453:epidemiology* / Q000235:genetics*; D005260:Female; D005819:Genetic Markers / Q000235:genetics; D020022:Genetic Predisposition to Disease / Q000453:epidemiology* / Q000235:genetics*; D006801:Humans; D015994:Incidence; D038622:Internationality; D008297:Male; D054526:Men's Health / Q000706:statistics & numerical data / Q000639:trends; D012307:Risk Factors; D012727:Sex Characteristics; D017678:Sex Distribution; D016387:Women's Health / Q000706:statistics & numerical data / Q000639:trends
D005819:Genetic Markers